BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10910007)

  • 1. Reversal of type 2 diabetes in mice by products of malaria parasites: I. Effect of inactivated parasites.
    Elased KM; de Souza JB; Playfair JH
    Metabolism; 2000 Jul; 49(7):937-41. PubMed ID: 10910007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs).
    Elased KM; Gumaa KA; de Souza JB; Rahmoune H; Playfair JH; Rademacher TW
    Mol Genet Metab; 2001 Jul; 73(3):248-58. PubMed ID: 11461192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of glucose homeostasis in obese diabetic db/db mice given Plasmodium yoelii glycosylphosphatidylinositols.
    Elased KM; Gumaa KA; de Souza JB; Playfair JH; Rademacher TW
    Metabolism; 2004 Aug; 53(8):1048-53. PubMed ID: 15281017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice.
    Howarth AG; Wiehler WB; Pannirselvam M; Jiang Y; Berger JP; Severson D; Anderson TJ; Triggle CR
    J Pharmacol Exp Ther; 2006 Jan; 316(1):364-70. PubMed ID: 16249369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 5-campestenone (24-methylcholest-5-en-3-one) on the type 2 diabetes mellitus model animal C57BL/KsJ-db/db mice.
    Suzuki K; Tanaka M; Konno R; Kaneko Y
    Horm Metab Res; 2002 Mar; 34(3):121-6. PubMed ID: 11972300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.
    Minoura H; Takeshita S; Ita M; Hirosumi J; Mabuchi M; Kawamura I; Nakajima S; Nakayama O; Kayakiri H; Oku T; Ohkubo-Suzuki A; Fukagawa M; Kojo H; Hanioka K; Yamasaki N; Imoto T; Kobayashi Y; Mutoh S
    Eur J Pharmacol; 2004 Jun; 494(2-3):273-81. PubMed ID: 15212984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary supplementation with cacao liquor proanthocyanidins prevents elevation of blood glucose levels in diabetic obese mice.
    Tomaru M; Takano H; Osakabe N; Yasuda A; Inoue K; Yanagisawa R; Ohwatari T; Uematsu H
    Nutrition; 2007 Apr; 23(4):351-5. PubMed ID: 17350804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
    Halseth AE; Ensor NJ; White TA; Ross SA; Gulve EA
    Biochem Biophys Res Commun; 2002 Jun; 294(4):798-805. PubMed ID: 12061777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-diabetic effects of ethanol extract from two variants of Artemisia princeps Pampanini in C57BL/KsJ-db/db mice.
    Jung UJ; Baek NI; Chung HG; Bang MH; Yoo JS; Jeong TS; Lee KT; Kang YJ; Lee MK; Kim HJ; Yeo JY; Choi MS
    Food Chem Toxicol; 2007 Oct; 45(10):2022-9. PubMed ID: 17574717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice.
    Shimomura Y; Bray GA; Lee M
    Horm Metab Res; 1987 Jul; 19(7):295-9. PubMed ID: 2957297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian hypercytolipidemia induced by obese (ob/ob) and diabetes (db/db) mutations: basis of female reproductive tract involution II.
    Garris DR
    Tissue Cell; 2004 Jun; 36(3):157-69. PubMed ID: 15140593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolipotoxicity-induced involution of the female reproductive tract following expression of obese (ob/ob) and diabetes (db/db) genotype mutations: progressive, hyperlipidemic transformation into adipocytic tissues.
    Garris DR; Garris BL
    Reprod Toxicol; 2004; 18(1):81-91. PubMed ID: 15013067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel terpenoid-type quinones isolated from Pycnanthus angolensis of potential utility in the treatment of type 2 diabetes.
    Luo J; Cheung J; Yevich EM; Clark JP; Tsai J; Lapresca P; Ubillas RP; Fort DM; Carlson TJ; Hector RF; King SR; Mendez CD; Jolad SD; Reaven GM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):529-34. PubMed ID: 9918555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic modulation of diabetes (db/db) and obese (ob/ob) mutation-induced hypercytolipidemia: cytochemical basis of female reproductive tract involution.
    Garris DR; Garris BL
    Cell Tissue Res; 2004 May; 316(2):233-41. PubMed ID: 15024641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of dehydroepiandrosterone (DHEA) and its metabolites in obese-hyperglycemic mutant mice.
    Coleman DL
    Prog Clin Biol Res; 1988; 265():161-75. PubMed ID: 2970093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice.
    Fromenty B; Vadrot N; Massart J; Turlin B; Barri-Ova N; Lettéron P; Fautrel A; Robin MA
    J Pharmacol Exp Ther; 2009 Oct; 331(1):23-34. PubMed ID: 19587315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
    Garris DR; Garris BL
    Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.
    Roy S; Khanna V; Mittra S; Dhar A; Singh S; Mahajan DC; Priyadarsiny P; Davis JA; Sattigeri J; Saini KS; Bansal VS
    Life Sci; 2007 Jun; 81(1):72-9. PubMed ID: 17532347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.